Certara, Inc. vs its peers
The 7 largest Health Care Technology companies by market value, prices of Nov 20, 2026
Certara, Inc. is the 5th largest of the 7 biggest Health Care Technology companies on OQRO by market value, at $1.61B. Its revenue of $419M in fiscal 2025 ranks 6th of 7. It keeps 5% of revenue as operating profit, 6th of 7 (median 23%). Revenue grew 9% on the year before, against a median of +8.7%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veeva SystemsVEEV · FY2026 | $43.1B | $3.2B | +16.3% | +16.9% | 75.5% | 28.7% | 28.4% | — | 24.0% | 47.4x | 13.5x | — | −1.6% |
| SolventumSOLV · FY2025 | $14.3B | $8.32B | +0.9% | — | 53.5% | 26.2% | 18.7% | −0.1% | — | 9.2x | 1.7x | −0.1% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- DOCS33%
- VEEV29%
- SOLV26%
- WAY23%
- HSTM7%
- CERT5%
- OMCL0%
Revenue growth, latest year
- WAY+16.5%
- VEEV
Compare Certara, Inc. head to head
Where Certara, Inc.’s revenue comes from and where it goes: Certara, Inc. revenue breakdown. Twenty years of results: Certara, Inc. financial history.
Common questions
Who are Certara, Inc.'s competitors?
The largest companies in its industry (Health Care Technology) by market value: Veeva Systems (VEEV), Solventum (SOLV), Doximity (DOCS), Waystar Holding Corp (WAY), Omnicell (OMCL) and HealthStream, Inc. (HSTM). They share Certara, Inc.'s industry listing; not every one competes with it on every product.
Is Certara, Inc. bigger than Veeva Systems?
No, by market value: Certara, Inc. is worth $1.61B and Veeva Systems $43.1B. By revenue, Certara, Inc. brought in $419M in fiscal 2025 and Veeva Systems $3.2B in fiscal 2026.
How does Certara, Inc.'s valuation compare with its peers?
Certara, Inc. trades at 3.8x its annual revenue. The median of the other 6 companies is 3.6x revenue and 44.7x earnings. A higher ratio means investors pay more for each dollar the company makes today, usually because they expect it to grow faster.
Where these figures come from
The group is the companies OQRO lists in the same industry as Certara, Inc. (Health Care Technology), the largest 6 by market value, plus Certara, Inc.. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.






